| Market Cap | ₹22Cr |
| ROE | -17.64% |
| P/E Ratio(TTM) | -13.86 |
| EPS(TTM) | -0.21 |
| P/B Ratio | 2.39 |
| Dividend Yield | 0.00% |
| Industry P/E | 58.90 |
| Book Value | 1.22 |
| Debt to Equity | 1.79 |
| Face Value | 10 |
| Parent Organisation | Transgene Biotek Limited |
| Managing Director | Dr. K. Koteswara Rao |
| Founded | 1990 |
| BSE Symbol | 526139 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Max Financial Services | NA (0.00%) | 290.34 | ||
| JSW Infrastructure | NA (0.00%) | 36.15 | ||
| Central Depository Services (India) | NA (0.00%) | 66.32 | ||
| Aegis Vopak Terminals | NA (0.00%) | 160.89 |